Cheryl Cohen
Director
Common Stock
- Value context
- $166.82K
- Reported price
- $2.98 / share
ImmunityBio, Inc.
Last 30 daysNo qualifying insider buying. Sales: $1.12M by 2 insiders.
Showing the first 6 of 20 trades on this page.
Director
Common Stock
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
Director
Common Stock
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockOption exercise or conversion10b5-1 | 55,979$2.98 / share | $166.82K | Oct 2Filed Oct 6 · 4d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units55,979$2.98 exercise / conversion price | Not a separate purchase | Oct 2Filed Oct 6 · 4d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 55,979$2.98 / share | $166.82K | Jul 2Filed Jul 6 · 4d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units55,979$2.98 exercise / conversion price | Not a separate purchase | Jul 2Filed Jul 6 · 4d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 35,064$2.98 / share | $104.49K | Jul 1Filed Jul 6 · 5d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 124,414$2.99 / share | $372K | Jul 1Filed Jul 6 · 5d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units35,064$2.98 exercise / conversion price | Not a separate purchase | Jul 1Filed Jul 6 · 5d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units124,414$2.99 exercise / conversion price | Not a separate purchase | Jul 1Filed Jul 6 · 5d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 32,173$2.98 / share | $95.88K | Jun 29Filed Jul 1 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 33,549$2.99 / share | $100.31K | Jun 29Filed Jul 1 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 30,000$2.84 / share | $85.2K | Jun 29Filed Jul 1 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 700$2.98 / share | $2.09K | Jun 30Filed Jul 1 · 1d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 300$2.99 / share | $897 | Jun 30Filed Jul 1 · 1d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units32,173$2.98 exercise / conversion price | Not a separate purchase | Jun 29Filed Jul 1 · 2d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units33,549$2.99 exercise / conversion price | Not a separate purchase | Jun 29Filed Jul 1 · 2d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units30,000$2.84 exercise / conversion price | Not a separate purchase | Jun 29Filed Jul 1 · 2d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units700$2.98 exercise / conversion price | Not a separate purchase | Jun 30Filed Jul 1 · 1d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units300$2.99 exercise / conversion price | Not a separate purchase | Jun 30Filed Jul 1 · 1d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units65,600Award · no purchase price | Non-cash award | Jun 9Filed Jun 10 · 1d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units65,600Award · no purchase price | Non-cash award | Jun 9Filed Jun 10 · 1d later | SEC filing |
Showing the latest 20 of 26 trades. Show all 26 trades
This reflects the filings imported so far, not a complete trading history.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.